96 filings
ARS
2023 FY
ACLX
Arcellx Inc
11 Apr 24
Annual report to shareholders
4:48pm
DEFA14A
ACLX
Arcellx Inc
11 Apr 24
Additional proxy soliciting materials
4:35pm
DEF 14A
ACLX
Arcellx Inc
Definitive proxy
11 Apr 24
4:26pm
8-K
ACLX
Arcellx Inc
14 Mar 24
Changes in Registrant's Certifying Accountant
4:15pm
10-K
2023 FY
ACLX
Arcellx Inc
Annual report
28 Feb 24
4:05pm
8-K
edagi2sqqonygcdx3x
28 Feb 24
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
4:02pm
8-K
jfgkcfh 6ar1gftlu
31 Jan 24
Termination of a Material Definitive Agreement
4:19pm
S-8
ujsp2 xjen66m7vf2r
2 Jan 24
Registration of securities for employees
4:22pm
8-K
x8z8ca
28 Dec 23
Other Events
4:47pm
8-K
chsw c0znbg
12 Dec 23
Other Events
7:37am
8-K
3rm7zh3ts4kpl
8 Dec 23
Arcellx Announces Continued Robust Long-Term Responses from Its
5:16pm
8-K
ud4r 1xpg0qdx8o00
15 Nov 23
Arcellx and Kite Announce Expansion In Strategic Partnership
6:16am
8-K
q93z35ru14dfkv
13 Nov 23
Arcellx Provides Third Quarter 2023 Financial Results and Business Highlights
4:05pm
8-K
vxmvvf9
2 Nov 23
Other Events
9:13am
8-K
25f 64ruw5me
14 Aug 23
Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results
4:06pm
8-K
4rnpi0
20 Jun 23
Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program
6:10am
8-K
g9iwi p86r
14 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
UPLOAD
x9zet0e39tsl
2 Jun 23
Letter from SEC
12:00am